Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram plus CBT versus CBT plus placebo for social anxiety disorder with neuroimaging outcomes
2010-023007-10Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of escitalopram in Social Anxiety Disorder (SAD) (3 arms), sponsored by Uppsala University. Primary endpoint: Brain activity assessed by fMRI BOLD signal. Started Jan 2011; status: completed.
02
Drugs
escitalopram
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on 2010-023007-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023007-10.